A Turkish medical firm’s “Extender” method is 96% effective for the treatment of peripheral arterial patients, the company said Friday.
According to INVAMED, Extender drug-eluting balloon application enables targeted drug delivery with high-efficiency drug transfer in peripheral arterial disease and provides an effective treatment in the disease in the long term.
The statement also urged that the patients should pay attention to symptoms of peripheral artery disease.
With rises in cardiovascular diseases in recent years, an average of 200,000 patients in Türkiye are diagnosed with peripheral arterial disease, particularly among those aged 50 and over, it added.
The statement also said those with leg pain triggered by physical activity may have peripheral artery disease.
The Peripheral artery disease, known as arterial occlusion, is caused by stenosis and occlusions, usually due to excess cholesterol and fat that mostly develops in legs and feet.
Turkish medical firm’s method 96% effective for peripheral arterial patients
Russia uses 'entire diplomatic arsenal' to oppose Western arms deliveries to Ukraine
Greece continues to violate human rights of Turkish minority, says Ankara
Oil prices surge over supply disruptions on Canada-US oil pipeline
India needs more efforts to boost digital literacy among women: Experts
Russia suspects arson in massive Moscow fire: Local media
LEGAL WARNING: BIST name and logo are protected under the "Protection Trademark Certificate" and cannot be used, quoted or changed without permission. The copyrights of all information disclosed under the name of BIST belong entirely to BIST and cannot be republished. Market data DirectFN Finansal Veri ve Teknoloji Hizmetleri Ltd. Şti. provided by. BIST stock data is delayed by 15 minutes.